CNIH Activators consist of a diverse set of chemical compounds that facilitate the functional activity of CNIH, a transmembrane protein integral to calcium-dependent signaling and protein kinase pathways. The mechanisms of these activators are varied, with some affecting intracellular trafficking, others modulating kinase activity, and several influencing calcium dynamics. Brefeldin A enhances CNIH's functionality by promoting its proper intracellular localization, a key factor in its overall performance. Forskolin, IBMX, 6-Bnz-cAMP, Verapamil, and RHC 80267, on the other hand, activate the PKA pathway or increase cAMP levels, leading to phosphorylation of CNIH and consequently, its activation.
In addition to the aforementioned compounds, Thapsigargin and Ionomycin augment the activity of CNIH by manipulating calcium levels within the cell. As CNIH is a calcium-dependent protein, these compounds indirectly enhance CNIH's functional activity by altering the calcium dynamics. PMA, Staurosporine, and OAG are activators of PKC, and by triggering PKC, they induce the phosphorylation and activation of CNIH. Finally, Okadaic Acid, an inhibitor of protein phosphatases, can enhance the activity of CNIH indirectly.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is an agent that disrupts protein transport from the endoplasmic reticulum to the Golgi apparatus. CNIH, a transmembrane protein, relies on this transport system for its proper cellular localization. Therefore, Brefeldin A can enhance the activity of CNIH by promoting its correct intracellular trafficking. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, leading to increased levels of cAMP and activation of the PKA pathway. CNIH is known to be phosphorylated by PKA, so Forskolin can enhance CNIH activity by stimulating this kinase. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, causing an increase in cAMP levels. Being a potential target of PKA, CNIH's activity can be enhanced by IBMX through the increase in PKA activity due to elevated cAMP. | ||||||
Adenosine 3′,5′-cyclic Monophosphate, N6-Benzoyl-, Sodium Salt | 30275-80-0 | sc-300167 | 10 µmol | $324.00 | 1 | |
6-Bnz-cAMP is a specific activator of PKA. As CNIH can be phosphorylated by PKA, 6-Bnz-cAMP can enhance the activity of CNIH by directly stimulating this kinase. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytoplasmic calcium. As CNIH is calcium-dependent, Thapsigargin can enhance the activity of CNIH by increasing intracellular calcium levels. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Given that CNIH is a calcium-dependent protein, Ionomycin can enhance the activity of CNIH by increasing the availability of calcium. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC), which can phosphorylate CNIH. Therefore, PMA can enhance the activity of CNIH by directly activating this kinase. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor, but at low concentrations, it can selectively activate PKC. Since CNIH can be phosphorylated by PKC, Staurosporine can enhance the activity of CNIH by selectively activating this kinase. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is an inhibitor of protein phosphatases PP1 and PP2A. By inhibiting these phosphatases, Okadaic Acid can enhance the phosphorylation state of CNIH, thereby enhancing its activity. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that can indirectly lead to activation of the PKA pathway. Given that CNIH can be phosphorylated by PKA, Verapamil can enhance the activity of CNIH by increasing PKA activity. | ||||||